Get the Stockscreener App
8.69
4.70%
0.39
Pre-market:
8.95
0.26
+2.99%
Neuraxis Inc stock is traded at $8.69, with a volume of 442.85K.
It is up +4.70% in the last 24 hours and up +19.86% over the past month.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$8.30
Open:
$8.37
24h Volume:
442.85K
Relative Volume:
2.59
Market Cap:
$99.98M
Revenue:
$3.57M
Net Income/Loss:
$-7.80M
P/E Ratio:
-8.956
EPS:
-0.9703
Net Cash Flow:
$-6.56M
1W Performance:
+14.19%
1M Performance:
+19.86%
6M Performance:
+242.13%
1Y Performance:
+323.90%
1-Day Range:
$8.26
$9.33
1-Week Range:
$7.17
$9.33
52-Week Range:
$1.942
$9.33
Neuraxis Inc Stock (NRXS) Company Profile
Name
Neuraxis Inc
Sector
Industry
Phone
(812) 689-0791
Address
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
8.69 | 99.98M | 3.57M | -7.80M | -6.56M | -0.9703 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Neuraxis Inc Stock (NRXS) Latest News
NeurAxis will post first-quarter results before market open May 12 - Stock Titan
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 - GlobeNewswire
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis - Yahoo! Finance Canada
Bigger Capital, Michael Bigger report NRXS holdings (NRXS) and warrant limits - Stock Titan
NeurAxis (NRXS) 10K Form and Latest SEC Filings 2026 - MarketBeat
Neuraxis (NRXS) director Gil reports stock awards from Series B dividend - Stock Titan
NRXS Ownership | NEURAXIS INC (NYSEARCA:NRXS) - ChartMill
Neuraxis (NRXS) asks investors to expand 2022 stock plan and approve ESPP - Stock Titan
NeurAxis (NRXS) price target increased by 21.43% to 8.67 - MSN
NeurAxis (NASDAQ:NRXS) Trading Up 5.5%Here's What Happened - MarketBeat
NRXS Forecast, Price Target & Analyst Ratings | NEURAXIS INC (NYSEARCA:NRXS) - ChartMill
NeurAxis Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Neuraxis increases at-the-market offering capacity to $11.5 million on NYSE American - Investing.com India
Neuraxis increases ATM capacity to $11.5M after $6.27M program sales - TradingView
Neuraxis (NRXS) boosts at-the-market share sale capacity to $11.5M - Stock Titan
Neuraxis, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Trading Information (April 21, 2026) 345726 - Minichart
NeurAxis Inc (NYSEARCA:NRXS) Shows Strong Technical and Fundamental Momentum - ChartMill
1.25 million more people gain access to NeurAxis' IBS pain device - Stock Titan
Neuraxis reports preliminary first quarter financial results, expects higher net sales By Investing.com - Investing.com South Africa
Neuraxis reports preliminary first quarter financial results, expects higher net sales - Investing.com Canada
According to its latest filing with the US Securities and Exchange Commission (SEC), neuro-regulation technology company Neuraxis Inc. expects net sales to reach approximately $1.6 million for the first quarter ending March 31, 2026. - Bitget
Neuraxis Inc Expects Net Sales Of About $1.6 Million For Three Months Ended March 31, 2026 - TradingView
Neuraxis (NYSE: NRXS) releases preliminary Q1 2026 financial results - Stock Titan
Neuraxis (NRXS) raises at‑the‑market capacity to $11.5M via Craig‑Hallum - Stock Titan
Is Neuraxis (NRXS) stock rejecting resistance (Bearish Momentum) 2026-04-18Market Timing - Xã Thanh Hà
Neuraxis (NRXS) Stock: Is It Approaching Resistance (Trend Weakens) 2026-04-18Volatility Breakout - Cổng thông tin điện tử tỉnh Lào Cai
Moving Averages: Is NeurAxis Inc a strong growth stock2026 Trading Recap & Verified Entry Point Signals - baoquankhu1.vn
Meme Stocks: Is NeurAxis Inc likely to announce a buybackWeekly Market Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn
Support Test: Will NeurAxis Inc stock hit new highs in YEAR2026 Earnings Surprises & Low Risk High Win Rate Picks - baoquankhu1.vn
Targets Report: Whats next for NeurAxis Inc stockLong Setup & Daily Market Momentum Tracking - baoquankhu1.vn
Energy Moves: Is NeurAxis Inc impacted by rising ratesQuarterly Portfolio Summary & Risk Managed Trade Strategies - baoquankhu1.vn
NeurAxis, Inc. Declares Stock Dividend on Series B Preferred Stock - Quiver Quantitative
NeurAxis, Inc. Announces Preferred Stock Dividend - Caledonian Record
Technical Analysis: Can NeurAxis Inc reach all time highs this yearEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Big Picture: Does NeurAxis Inc meet Warren Buffetts criteriaWeekly Trend Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Winners Losers: Does NeurAxis Inc have pricing powerQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
NeurAxis (NASDAQ:NRXS) CFO Buys $14,882.28 in Stock - Defense World
NRXS PE Ratio & Valuation, Is NRXS Overvalued - Intellectia AI
Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys - TipRanks
Neuraxis CEO Carrico buys $15,797 in company stock By Investing.com - Investing.com Australia
Neuraxis CFO Henrichs buys $14,882 in company stock - Investing.com
Neuraxis Inc: CRO Carrico buys $1307 in shares By Investing.com - Investing.com India
Neuraxis CFO Henrichs buys $14,882 in company stock By Investing.com - Investing.com South Africa
Insider Buying: NeurAxis (NASDAQ:NRXS) CFO Buys 7,593 Shares of Stock - MarketBeat
Insider Buying: NeurAxis (NASDAQ:NRXS) CEO Buys 8,060 Shares of Stock - MarketBeat
Neuraxis CEO Carrico buys $15,797 in company stock - Investing.com
Neuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade - Stock Titan
Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan
Neuraxis (NRXS) CEO boosts stake with open-market buy of 8,060 shares - Stock Titan
Aug Final Week: Is NeurAxis Inc a speculative investmentVolume Spike & Real-Time Stock Movement Alerts - baoquankhu1.vn
New Highs: Can NeurAxis Inc expand its profit marginsQuarterly Investment Review & Real-Time Stock Entry Alerts - baoquankhu1.vn
Neuraxis Inc Stock (NRXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Cap:
|
Volume (24h):